A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro
- PMID: 618577
Item in Clipboard
A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro
Cancer Res.
1978 Jan.
Abstract
The inhibitory effect of methotrexate on [3H]deoxyuridine incorporation into DNA is reduced as the basal rate of this reaction is inhibited by pretreatment of Ehrlich ascites tumor cells with fluoropyrimidines. This observation is a basis for fluoropyrimidine-methotrexate antagonism in anticancer regimens and supports the concept that the sensitivity of thymidylate synthesis in tumor cells to methotrexate is related, in part, to the basal rate of thymidylate synthesis from deoxyuridylate.
Similar articles
-
Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.Cancer Res. 1976 May;36(5):1653-8. Cancer Res. 1976. PMID: 1268826
-
The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.Mol Pharmacol. 1974 Mar;10(2):275-82. Mol Pharmacol. 1974. PMID: 4859543 No abstract available.
-
Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.Eur J Cancer Clin Oncol. 1984 May;20(5):651-7. doi: 10.1016/0277-5379(84)90012-9. Eur J Cancer Clin Oncol. 1984. PMID: 6234172
-
The thymidylate synthesis cycle and anticancer drugs.Med Res Rev. 1987 Oct-Dec;7(4):441-75. doi: 10.1002/med.2610070405. Med Res Rev. 1987. PMID: 3309507 Review. No abstract available.
-
The clinical pharmacology of antineoplastic agents (first of two parts).N Engl J Med. 1975 May 22;292(21):1107-13. doi: 10.1056/NEJM197505222922107. N Engl J Med. 1975. PMID: 124015 Review. No abstract available.
Cited by
-
Clinical pharmacology of 5-fluorouracil.Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002. Clin Pharmacokinet. 1989. PMID: 2656050 Review.
-
Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.Cancer Chemother Pharmacol. 1985;15(3):214-9. doi: 10.1007/BF00263888. Cancer Chemother Pharmacol. 1985. PMID: 3876889
-
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.Breast Cancer Res Treat. 1982;2(1):93-9. doi: 10.1007/BF01805721. Breast Cancer Res Treat. 1982. PMID: 6293630
-
Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.Proc Natl Acad Sci U S A. 1979 Nov;76(11):5924-8. doi: 10.1073/pnas.76.11.5924. Proc Natl Acad Sci U S A. 1979. PMID: 160558 Free PMC article.
-
The interaction between fluoropyrimidines and methotrexate, and [4C]-formate incorporation into nucleic acids and protein.Cancer Chemother Pharmacol. 1980;4(2):111-6. doi: 10.1007/BF00254031. Cancer Chemother Pharmacol. 1980. PMID: 6446421